DPP4 and hepatocellular carcinoma: The Kaplan-Meier survival analysis demonstrated a significantly higher HCC-free rate in the DPP-4 inhibitor group than in the non-DPP-4 inhibitor group (log-rank test, P = 0.001; Figure 1).